Skip to main content

Flammer Martina M.D.'s Form 4 filing

INSMED IncINSM · filed Jan 8, 2026

Accession no.
0001796960-26-000004
Filed
Jan 8, 2026
Trade date
Jan 6-8, 2026
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 8 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.88M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Flammer Martina M.D.CIK 0001796960Officer (Chief Medical Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 6, 2026Common StockMOption exerciseAcquired+8,570$26.43+$226,505.1103,324Direct
Jan 6, 2026Common StockSSaleDisposed−4,783$173.47F2−$829,707.0198,541Direct
Jan 6, 2026Common StockSSaleDisposed−2,830$174.21F3−$493,014.395,711Direct
Jan 6, 2026Common StockSSaleDisposed−957$175.01F4−$167,484.5794,754Direct
Jan 6, 2026Common StockSSaleDisposed−1,615$173.33−$279,927.9593,139Direct
Jan 7, 2026Common StockSSaleDisposed−1,434$175.84F6−$252,154.5691,705Direct
Jan 8, 2026Common StockSSaleDisposed−1,660$173.87F7−$288,624.290,045Direct
Jan 8, 2026Common StockSSaleDisposed−3,251$174.17−$566,226.6786,794Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 6, 2026Common StockMOption exerciseDisposed−8,570$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This is the weighted average sales price representing 4,783 shares sold at prices ranging from $172.89 to $173.87 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Referenced by the price of 1 transaction in Table I.

F3

This is the weighted average sales price representing 2,830 shares sold at prices ranging from $173.92 to $174.80 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Referenced by the price of 1 transaction in Table I.

F4

This is the weighted average sales price representing 957 shares sold at prices ranging from $174.97 to $175.12 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Referenced by the price of 1 transaction in Table I.

F6

This is the weighted average sales price representing 1,434 shares sold at prices ranging from $175.72 to $176.00 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Referenced by the price of 1 transaction in Table I.

F7

This is the weighted average sales price representing 1,660 shares sold at prices ranging from $173.87 to $173.90 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)